Basal cell carcinoma

Cancer. 2000 Sep 1;89(5):1012-8. doi: 10.1002/1097-0142(20000901)89:5<1012::aid-cncr10>3.0.co;2-o.

Abstract

Background: Basal cell carcinoma (BCC) is characterized by marked interpatient variation in tumor accrual. The authors previously reported that presentation with a cluster of BCC is associated with an inherited predisposition to develop many additional lesions suggesting clustering is a critical event. A cluster is defined as the presence of two or more new, primary BCCs, at initial or later presentation.

Methods: The authors recruited 927 cases and determined whether 1) clustering was an early or late event and 2) tumor accrual was altered after clustering.

Results: In the cases, 669 patients developed only 1 lesion, 112 patients presented more than once but with single lesions (single presentation phenotype[SPP]-more), 94 cases had a cluster at first presentation (multiple presentation phenotype [MPP]-cluster initial), and 52 cases first presented with 1 lesion but later had a cluster (MPP-cluster later). The authors found that 1) clustering occurred relatively late. The mean ages at first presentation with 1 BCC of the SPP-more (61.5 years) and MPP-cluster later patients (60.4 years) were similar although presentations with clusters in the MPP-cluster initial (67.6 years, P = 0.0002) and -cluster later cases (68.1 years, P = 0.002) occurred significantly later. 2) Clustering was associated with increased accrual. Thus, 26 patients (MPP-cluster later/a) in the MPP-cluster later group had a additional BCC postcluster. Mean accrual post-cluster (1.99 BCC/year) in these cases was significantly increased (P = 0.0001) compared with precluster accrual (0.39 BCC/year).

Conclusions: The authors found that the formation of BCC clusters represents a critical event such that after a cluster presentation, tumor accrual is significantly increased. Cluster presentation is a relatively late event suggesting reduced effectiveness in immune surveillance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Carcinoma, Basal Cell / classification
  • Carcinoma, Basal Cell / epidemiology
  • Carcinoma, Basal Cell / genetics
  • Carcinoma, Basal Cell / physiopathology*
  • Data Interpretation, Statistical
  • Genetic Predisposition to Disease
  • Humans
  • Middle Aged
  • Models, Biological
  • Neoplasms, Multiple Primary / epidemiology
  • Neoplasms, Multiple Primary / etiology*
  • Phenotype
  • Skin Neoplasms / classification
  • Skin Neoplasms / epidemiology
  • Skin Neoplasms / genetics
  • Skin Neoplasms / physiopathology*